Filtered By:
Specialty: International Medicine & Public Health

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 794 results found since Jan 2013.

Treatments for people with early COVID-19 infection is an urgent research focus
(NIH/National Institute of Allergy and Infectious Diseases) COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues. Treating people early in the course of infection with SARS-CoV-2, the virus that causes COVID-19, would speed their recovery, reduce the likelihood that they develop severe outcomes and reduce demand on the healthcare system, they write.
Source: EurekAlert! - Medicine and Health - November 11, 2020 Category: International Medicine & Public Health Source Type: news

The Covid Pandemic: Broadening the Discourse
Thailand’s COVID-19 response an example of resilience and solidarity: a UN Resident Coordinator’s BlogBy Asoka BandarageCOLOMBO, Sri Lanka, Nov 10 2020 (IPS) SARS-CoV-2, the corona virus that causes COVID-19, has been spreading exponentially across the world over the last ten or so months. As of November 6th, according to the Center for Systems Science at Johns Hopkins University, there have been 49,195,581 cases of COVID-19, including 1,241,031 deaths. More than a third of the global population has been placed on lockdown. The global economy is experiencing the deepest global recession since World War 2 and massive n...
Source: IPS Inter Press Service - Health - November 10, 2020 Category: International Medicine & Public Health Authors: Asoka Bandarage Tags: Featured Global Headlines Health Human Rights Humanitarian Emergencies Peace TerraViva United Nations Source Type: news

Food allergy-related bullying and associated peer dynamics among Black and White children in FORWARD Study - Brown D, Negris O, Gupta R, Herbert L, Lombard L, Bozen A, Assa'ad A, Chura A, Andy-Nweye AB, Fox S, Mahdavinia M, Tobin M, Robinson A, Sharma H, Coleman A, Jiang J, Bilaver L, Fierstein JL, Galic I, Newmark P, Pongracic JA, Pappalardo AA, Warren C.
BACKGROUND: The experiences of Black children with food allergy (FA) are not well characterized, particularly with respect to bullying victimization and other psychosocial outcomes. OBJECTIVE: To examine bullying experiences of Black and White children...
Source: SafetyLit - November 9, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Immunotherapy of allergies: current status.
This article provides an up-to-date overview of immunological, regulatory and practical aspects of AIT. Current literature was included and recent conceptual regulatory developments from the Division of Allergology at the higher federal authority (Paul-Ehrlich-Institut) are presented.The 62 AIT products currently approved in Germany and further 61 AIT products under the development program of the Therapy Allergen Ordinance (TAO) include 95 products for subcutaneous (SCIT) and 28 for sublingual (SLIT) treatment of birch/alder/hazel pollen, grass pollen, weed pollen, house dust mite and insect venom allergies. Native and ...
Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz - November 2, 2020 Category: International Medicine & Public Health Authors: Mahler V, Kleine-Tebbe J, Vieths S Tags: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Source Type: research

How allergens trigger itching: Finding points to new targets for allergy drug development
(Massachusetts General Hospital) A key step in the immune system's response to allergens has been uncovered by researchers at Massachusetts General Hospital. They have shown that a neuropeptide called Substance P is released by certain neurons in the skin when they detect allergens, and that this substance is essential in the development of allergen-induced immune responses. This research could lead to the development of new and better methods to treat and prevent allergies.
Source: EurekAlert! - Medicine and Health - October 29, 2020 Category: International Medicine & Public Health Source Type: news

Recombinant allergens, peptides, and virus-like particles for allergy immunotherapy.
This article provides an overview of published molecular approaches for allergy treatment used in clinical AIT studies. Their added value and challenges compared to established therapeutic allergens are discussed. The aim of these approaches is to develop highly effective and well-tolerated AIT preparations with improved patient acceptance and adherence. PMID: 33095280 [PubMed - as supplied by publisher]
Source: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz - October 23, 2020 Category: International Medicine & Public Health Authors: Holzhauser T, Schuler F, Dudek S, Kaul S, Vieths S, Mahler V Tags: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Source Type: research

Bayesian Stacked Parametric Survival with Frailty Components and Interval ‐Censored Failure Times: An Application to Food Allergy Risk
AbstractTo better understand the risk of exposure to food allergens, food challenge studies are designed to slowly increase the dose of an allergen delivered to allergic individuals until an objective reaction occurs. These dose ‐to‐failure studies are used to determine acceptable intake levels and are analyzed using parametric failure time models. Though these models can provide estimates of the survival curve and risk, their parametric form may misrepresent the survival function for doses of interest. Different models that describe the data similarly may produce different dose‐to‐failure estimates. Motivated by p...
Source: Risk Analysis - October 16, 2020 Category: International Medicine & Public Health Authors: Matthew W. Wheeler, Joost Westerhout, Joe L. Baumert, Benjamin C. Remington Tags: Original Research Article Source Type: research

NIH study aims to identify promising COVID-19 treatments for larger clinical trials
(NIH/National Institute of Allergy and Infectious Diseases) The National Institute of Allergy and Infectious Diseases today launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage clinical development show promise against COVID-19 and merit advancement into larger clinical trials. The ACTIV-5 Big Effects Trial, which will enroll adult volunteers hospitalized with COVID-19 at as many as 40 U.S sites, is being conducted in collaboration with the NIH's public-private partnership Accelerating COVID-19 Therapeutic Innovations and Vaccines (ACTIV) program.
Source: EurekAlert! - Medicine and Health - October 13, 2020 Category: International Medicine & Public Health Source Type: news

Comparison of Atmospheric Fungal Spore Concentrations between Two Main Cities in the Caribbean Basin.
CONCLUSION: Our study provides additional evidence to help design allergy interventions. PMID: 33031690 [PubMed - as supplied by publisher]
Source: Puerto Rico Health Sciences Journal - October 10, 2020 Category: International Medicine & Public Health Tags: P R Health Sci J Source Type: research

Attend the 2020 ACAAI Annual Scientific Meeting from where you are sitting right now
(American College of Allergy, Asthma, and Immunology) This year's groundbreaking allergy and asthma news from the ACAAI Annual Scientific Meeting will be delivered virtually, and for free.
Source: EurekAlert! - Medicine and Health - September 18, 2020 Category: International Medicine & Public Health Source Type: news

Children's Hospital Los Angeles is US site for $7M study of COVID-19 transmission
(Children's Hospital Los Angeles) Researchers at The Saban Research Institute of Children's Hospital Los Angeles, as well as in Nicaragua and New Zealand, are enrolling 250-325 households in a new study designed to study how COVID-19 spreads within households. The study was awarded $7.1 million by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Source: EurekAlert! - Medicine and Health - September 14, 2020 Category: International Medicine & Public Health Source Type: news

Study finds babies born in fall at higher risk for allergic diseases
(MediaSource) Researchers at National Jewish Health have determined that many allergic conditions likely start with dry, cracked skin, which leads to a chain reaction of allergic diseases known as the atopic march. It begins in infancy with atopic dermatitis and leads to food allergies, asthma and hay fever. Their latest study in The Journal of Allergy and Clinical Immunology: In Practice reveals that the time of year a baby is born may be a risk factor.
Source: EurekAlert! - Social and Behavioral Science - September 9, 2020 Category: International Medicine & Public Health Source Type: news

NIAID establishes centers for research in emerging infectious diseases
(NIH/National Institute of Allergy and Infectious Diseases) The National Institute of Allergy and Infectious Diseases (NIAID) announced that it has awarded 11 grants with a total first-year value of approximately $17 million to establish the Centers for Research in Emerging Infectious Diseases. The global network will involve multidisciplinary investigations into how and where viruses and other pathogens emerge from wildlife and spillover to cause disease in people. NIAID intends to provide approximately $82 million over 5 years to support the network.
Source: EurekAlert! - Medicine and Health - August 27, 2020 Category: International Medicine & Public Health Source Type: news